solifenacin succinate has been researched along with Lower Urinary Tract Symptom in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 37 (97.37) | 24.3611 |
| 2020's | 1 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YB; Gao, L; Jiang, Q; Luo, RT; Ran, K | 1 |
| Kaplan, SA | 2 |
| Amri, I; Arbe, E; Bowditch, S; Drake, MJ; Guelfucci, F; Hakimi, Z; Nazir, J | 1 |
| Bai, B; Lei, Y; Mu, J; Wang, J; Zhang, T; Zhang, X | 1 |
| Henningsohn, L; Jacobsen, JL; Kilany, S; Svensson, M | 1 |
| Cantrell, MA; Goodson, AB; Lund, BC; Shaw, RF | 1 |
| Chen, Y; Jian, Z; Li, H; Liao, B; Liu, Q; Wang, K; Yang, T | 1 |
| Alcántara, A; Cózar, JM; Duran, A; Errando, C; Mora, AM; Rubio-Rodríguez, D; Rubio-Terrés, C | 1 |
| Gainullina, Y; Karashchuk, E; Kosilov, K; Kosilova, L; Kuzina, I; Kuznetsov, V; Loparev, S; Prokofyeva, A | 1 |
| Gadzhieva, ZK; Gazimiev, MA; Grigoryan, VA; Kazilov, YB | 1 |
| De Wachter, S; Foley, S; Huang, M; Rees, J; Rosa Arias, J; Skoumal, R; Walters, C; Yavuz, Y | 1 |
| Bogusiewicz, M; Kulik-Rechberger, B; Miotla, P; Rechberger, E; Rechberger, T; Wrobel, A; Zietek, A | 1 |
| Angulo, JC; Garcia-Hernandez, A; Haab, F; Katona, F; Klaver, M; Oelke, M; Traudtner, K; Van Kerrebroeck, P; Vik, V | 2 |
| Apostolidis, A | 1 |
| Chapple, C; Drake, MJ; Drogendijk, T; Klaver, M; Sokol, R; Speakman, M; Traudtner, K; van Kerrebroeck, P | 1 |
| Chapple, C; Drake, MJ; Drogendijk, T; Klaver, M; Oelke, M; Sokol, R; Traudtner, K; Van Kerrebroeck, P | 1 |
| Andersson, KE | 1 |
| Doo, SW; Kim, JH; Lee, SW; Yang, HJ; Yang, WJ; Yun, JH | 1 |
| Hyun, JS; Kim, SW; Ko, K; Lee, SW; Lee, WK; Moon, du G; Moon, KH; Park, JK; Park, K; Park, NC; Son, HC; Yang, DY | 1 |
| Blak, B; Hakimi, Z; Johnson, M; Nazir, J; Odeyemi, IA | 1 |
| De Nunzio, C; Presicce, F; Puccini, F; Tubaro, A | 1 |
| Crosby, RD; Drogendijk, T; Hakimi, Z; Klaver, M; Mathias, SD; Nazir, J; Odeyemi, IA | 1 |
| De Nunzio, C; Tubaro, A | 1 |
| Drake, MJ; Pandian, S; Romancik, M | 1 |
| Dimitropoulos, K; Gravas, S | 1 |
| Coyne, K; Dorey, J; Drake, MJ; Hakimi, Z; Klaver, M; Nazir, J; Odeyemi, IA; Oelke, M; Sokol, R; Traudtner, K; van Kerrebroeck, P | 1 |
| Hakimi, Z; Heemstra, L; Ivanescu, C; Nazir, J; van Engen, A | 1 |
| Deng, D; Dong, W; Gong, M; Gong, Z; Huang, G; Qiu, S; Yuan, R | 1 |
| Angulo, JC | 1 |
| Boone, TB; Chan, R; Miles, B; Munoz, A; Wenker, EP; Whipple, M | 1 |
| Choi, IS; Park, JK; Shin, YS; You, JH; Zhang, LT; Zhao, C | 1 |
| Bongaerts, D; Drake, MJ; Klaver, M; Oelke, M; Snijder, R; Traudtner, K; van Charldorp, K; Van Kerrebroeck, P | 1 |
| Abdel Raheem, A; Abo Farha, M; El-Tatawy, H; Elashry, O; Magdy, M; Ragab, M; Soliman, MG; Tawfik, A | 1 |
| Crosby, RD; Marshall, TS; Mathias, SD | 1 |
| Cummings, J; Fakhoury, A; He, W; Kaplan, SA; Koltun, WD; Schneider, T | 1 |
| Andersson, KE; Gratzke, C | 1 |
9 review(s) available for solifenacin succinate and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Tamsulosin Monotherapy Is Effective in Reducing Ureteral Stent-related Symptoms: A Meta-analysis of Randomized Controlled Studies.
Topics: Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Female; Humans; Lower Urinary Tract Symptoms; Male; Randomized Controlled Trials as Topic; Solifenacin Succinate; Stents; Tamsulosin; Treatment Outcome; Ureteral Diseases; Urological Agents | 2019 |
The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Flank Pain; Health Status; Hematuria; Humans; Lower Urinary Tract Symptoms; Muscarinic Antagonists; Postoperative Complications; Quality of Life; Solifenacin Succinate; Stents; Sulfonamides; Tamsulosin; Ureter; Xerostomia | 2017 |
Combination of solifenacin and tamsulosin may provide additional beneficial effects for ureteral stent-related symptoms-outcomes from a network meta-analysis.
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Network Meta-Analysis; Pain; Quinazolines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Stents; Tamsulosin; Treatment Outcome; Urinary Catheterization; Urological Agents | 2019 |
[The combined symptoms of male lower urinary tract: current treatment options].
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Treatment Outcome; Urinary Bladder | 2018 |
The use of pharmacotherapy for male patients with urgency and stress incontinence.
Topics: 5-alpha Reductase Inhibitors; Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Thiazoles; Urinary Bladder, Overactive; Urinary Incontinence, Stress; Urinary Incontinence, Urge; Urological Agents | 2014 |
Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment.
Topics: Acetylcholine Release Inhibitors; Botulinum Toxins, Type A; Drug Combinations; Humans; Laser Therapy; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatism; Solifenacin Succinate; Sulfonamides; Tadalafil; Tamsulosin; Transurethral Resection of Prostate; Urological Agents | 2015 |
Tamsulosin/solifenacin fixed-dose combination tablet for the treatment of male lower urinary tract symptoms.
Topics: Clinical Trials as Topic; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Urological Agents | 2014 |
Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia.
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin | 2015 |
Tamsulosin combined with solifenacin versus tamsulosin monotherapy for male lower urinary tract symptoms: a meta-analysis.
Topics: Drug Monitoring; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Outcome Assessment, Health Care; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Retention; Urological Agents | 2015 |
14 trial(s) available for solifenacin succinate and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
The Risk of Sexual Dysfunction and Effectiveness of Treatment of Benign Prostatic Hyperplasia With Severe Lower Urinary Tract Dysfunction With Combination of Dutasteride and Solifenacin.
Topics: Drug Therapy, Combination; Dutasteride; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Treatment Outcome; Urological Agents | 2018 |
Does Pharmacological Treatment Reduce the Incidence of Lower Urinary Tract Symptoms (LUTS) after Transobturator Sling?
Topics: Acetanilides; Adult; Aged; Female; Humans; Lower Urinary Tract Symptoms; Middle Aged; Prospective Studies; Solifenacin Succinate; Suburethral Slings; Thiazoles | 2019 |
Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Dosage Calculations; Drug Therapy, Combination; Europe; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urination; Urination Disorders; Urodynamics; Urological Agents | 2013 |
Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial.
Topics: Absorption; Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Tetrahydroisoquinolines | 2013 |
Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Chemistry, Pharmaceutical; Double-Blind Method; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urinary Retention; Urodynamics; Urological Agents | 2015 |
Can we decide the optimal initial treatment for male lower urinary tract symptoms patients with overactive bladder by the most bothersome symptom? A randomized, prospective, open-label study.
Topics: Aged; Decision Making; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Prostate; Quality of Life; Quinuclidines; Republic of Korea; Solifenacin Succinate; Sulfonamides; Symptom Assessment; Tamsulosin; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2014 |
Effect of improvement in lower urinary tract symptoms on sexual function in men: tamsulosin monotherapy vs. combination therapy of tamsulosin and solifenacin.
Topics: Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Quality of Life; Quinuclidines; Rheology; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tetrahydroisoquinolines; Treatment Outcome; Urological Agents | 2014 |
Validation of the Patient Perception of Intensity of Urgency Scale in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Psychometrics; Quinuclidines; Reproducibility of Results; Severity of Illness Index; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tetrahydroisoquinolines; Urological Agents | 2014 |
Responder and health-related quality of life analyses in men with lower urinary tract symptoms treated with a fixed-dose combination of solifenacin and tamsulosin oral-controlled absorption system: results from the NEPTUNE study.
Topics: Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urological Agents | 2016 |
Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2016 |
Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies.
Topics: Drug Combinations; Humans; Incidence; Lower Urinary Tract Symptoms; Male; Risk Factors; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Time Factors; Urinary Retention; Urological Agents | 2017 |
The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial.
Topics: Adult; Analgesics; Drug Therapy, Combination; Female; Flank Pain; Hematuria; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Pregabalin; Prospective Studies; Quality of Life; Sexual Dysfunction, Physiological; Single-Blind Method; Solifenacin Succinate; Stents; Surveys and Questionnaires; Ureter; Ureteral Calculi; Urological Agents | 2017 |
Relationships between symptoms, symptom bother, and health-related quality of life in patients with overactive bladder taking solifenacin or placebo in the VIBRANT study.
Topics: Analysis of Variance; Female; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Patient Satisfaction; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2011 |
Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Analysis of Variance; Double-Blind Method; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Pressure; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics | 2013 |
15 other study(ies) available for solifenacin succinate and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Re: The Risk of Sexual Dysfunction and Effectiveness of Treatment of Benign Prostatic Hyperplasia with Severe Lower Urinary Tract Dysfunction with Combination of Dutasteride and Solifenacin.
Topics: 5-alpha Reductase Inhibitors; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Solifenacin Succinate; Urinary Tract | 2020 |
A retrospective study of treatment persistence and adherence to α-blocker plus antimuscarinic combination therapies, in men with LUTS/BPH in the Netherlands.
Topics: Adrenergic alpha-Antagonists; Aged; Cohort Studies; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Medication Adherence; Middle Aged; Muscarinic Antagonists; Netherlands; Prostatic Hyperplasia; Retrospective Studies; Solifenacin Succinate; Tolterodine Tartrate | 2017 |
Patient-perceived effectiveness and impact on quality of life of solifenacin in combination with an α-blocker in men with overactive bladder in Sweden: a non-interventional study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Humans; Longitudinal Studies; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Patient Reported Outcome Measures; Patient Satisfaction; Quality of Life; Solifenacin Succinate; Sweden; Urinary Bladder, Overactive; Urological Agents | 2017 |
Comparative Effectiveness of Anticholinergic Agents for Lower Urinary Tract Symptoms.
Topics: Age Factors; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Comorbidity; Diabetes Mellitus; Female; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Multiple Sclerosis; Parkinson Disease; Retrospective Studies; Sex Factors; Solifenacin Succinate; Tolterodine Tartrate; United States; United States Department of Veterans Affairs | 2018 |
[Cost-effectiveness model of a fixed dose combination of solifenacin and tamsulosin for the treatment of LUTS associated with BPH with inadequate response to monotherapy.]
Topics: Adrenergic alpha-1 Receptor Antagonists; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Markov Chains; Models, Economic; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin; Treatment Outcome | 2018 |
Vesomni improves the quality of life in men with lower urinary tract symptoms in routine clinical practice in Europe.
Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Europe; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2019 |
Male lower urinary tract symptoms: a riddle waiting to be solved.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urination Disorders; Urological Agents | 2013 |
Reply from authors re: Apostolos Apostolidis. Male lower urinary tract symptoms: a riddle waiting to be solved. Eur Urol 2013;64:408-10: a rationale for combination antimuscarinic-α-blocker therapy for male lower urinary tract symptoms.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urination Disorders; Urological Agents | 2013 |
Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cresols; Family Practice; Humans; Lower Urinary Tract Symptoms; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Primary Health Care; Prostatic Hyperplasia; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Tolterodine Tartrate; United Kingdom | 2015 |
The evolving picture of lower urinary tract symptom management.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Urinary Bladder; Urinary Bladder, Overactive; Urinary Retention; Urological Agents | 2015 |
Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Administration, Oral; Aged; Aged, 80 and over; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Markov Chains; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urodynamics | 2015 |
Combination therapy with tamsulosin and solifenacin for male lower urinary tract symptoms with predominant filling symptoms: a new approach to an old problem.
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin | 2015 |
Solifenacin and Tamsulosin Combination Therapy Decreases Urine Nerve Growth Factor/Creatinine Levels in Men.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Creatinine; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Nerve Growth Factor; Pilot Projects; Solifenacin Succinate; Sulfonamides; Tamsulosin | 2016 |
Re: Long-Term Safety and Efficacy of Single-Tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-Label Extensio
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Neptune; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Treatment Outcome | 2016 |
α-Blockers and antimuscarinics for male lower urinary tract symptoms: the search goes on.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urinary Bladder Neck Obstruction | 2013 |